All Stories

  1. The science of infectious diseases

    Article • Philosophical Transactions of the Royal Society B Biological Sciences, May 2014, Royal Society Publishing

    Christopher Dye

  2. After 2015: infectious diseases in a new era of health and development

    Article • Philosophical Transactions of the Royal Society B Biological Sciences, May 2014, Royal Society Publishing

    Christopher Dye

  3. Genotyping and Its Implications for Transmission Dynamics and Tuberculosis Control

    Article • April 2014, Taylor & Francis

    Christopher Dye

  4. Perspective: Weigh all TB risks

    Article • Nature, October 2013, Springer Science + Business Media

    Christopher Dye

  5. The Global Drug Facility and its role in the market for tuberculosis drugs

    Article • The Lancet, October 2013, Elsevier

    Christopher Dye

  6. Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered

    Article • Journal of The Royal Society Interface, July 2013, Royal Society Publishing

    Christopher Dye

  7. Prospects for Tuberculosis Elimination

    Article • Annual Review of Public Health, March 2013, Annual Reviews

    Christopher Dye

  8. A major event for new tuberculosis vaccines

    Article • The Lancet, March 2013, Elsevier

    Christopher Dye

  9. WHO and the future of disease control programmes

    Article • The Lancet, February 2013, Elsevier

    Christopher Dye

  10. The impact of new tuberculosis diagnostics on transmission: why context matters

    Article • Bulletin of the World Health Organization, October 2012, WHO Press

    Christopher Dye

  11. National and international policies to mitigate disease threats

    Article • Philosophical Transactions of the Royal Society B Biological Sciences, September 2012, Royal Society Publishing

    Christopher Dye

  12. Evaluation of Immigrant Tuberculosis Screening in Industrialized Countries

    Article • Emerging Infectious Diseases, September 2012, Centers for Disease Control and Prevention (CDC)

    Christopher Dye

  13. Drug-Resistant Tuberculosis in Zhejiang Province, China, 1999–2008

    Article • Emerging Infectious Diseases, March 2012, Centers for Disease Control and Prevention (CDC)

    Christopher Dye

  14. Worldwide Incidence of Malaria in 2009: Estimates, Time Trends, and a Critique of Methods

    Article • PLoS Medicine, December 2011, PLOS

    Christopher Dye

  15. Practical Preventive Therapy for Tuberculosis?

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, December 2011, New England Journal of Medicine (NEJM/MMS)

    Christopher Dye

  16. Role of acute infection in HIV transmission

    Article • The Lancet, December 2011, Elsevier

    Christopher Dye

  17. Nutrition, Diabetes and Tuberculosis in the Epidemiological Transition

    Article • PLoS ONE, June 2011, PLOS

    Christopher Dye

  18. Highly active antiretroviral treatment for the prevention of HIV transmission

    Article • Journal of the International AIDS Society, January 2010, Wiley

    Christopher Dye

  19. Drivers of tuberculosis epidemics: The role of risk factors and social determinants

    Article • Social Science & Medicine, June 2009, Elsevier

    Christopher Dye

  20. Universal voluntary HIV testing and immediate antiretroviral therapy – Authors' reply

    Article • The Lancet, March 2009, Elsevier

    Christopher Dye

  21. Mathematical models of the epidemiology and control of drug-resistant TB

    Article • Expert Review of Respiratory Medicine, February 2009, Taylor & Francis

    Christopher Dye

  22. Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis

    Article • Nature Reviews Microbiology, January 2009, Springer Science + Business Media

    Christopher Dye

  23. Spatial Analysis of Tuberculosis Cases in Migrants and Permanent Residents, Beijing, 2000–2006

    Article • Emerging Infectious Diseases, September 2008, Centers for Disease Control and Prevention (CDC)

    Christopher Dye

  24. Spatial Analysis of Tuberculosis Cases in Migrants and Permanent Residents, Beijing, 2000–2006

    Article • Emerging Infectious Diseases, September 2008, Centers for Disease Control and Prevention (CDC)

    Christopher Dye

  25. Alcohol use as a risk factor for tuberculosis – a systematic review

    Article • BMC Public Health, August 2008, Springer Science + Business Media

    Christopher Dye

  26. Epidemiology

    Article • April 2008, Taylor & Francis

    Christopher Dye

  27. Breaking the law: tuberculosis disobeys Styblo's rule

    Article • Bulletin of the World Health Organization, January 2008, WHO Press

    Christopher Dye

  28. Economic benefit of Tuberculosis control

    Article • August 2007

    Christopher Dye, Dr Eili Y Klein

  29. Reply to Eisenhut

    Article • The Journal of Infectious Diseases, May 2007, Oxford University Press (OUP)

    Christopher Dye

  30. Did we reach the 2005 targets for tuberculosis control?

    Article • Bulletin of the World Health Organization, May 2007, WHO Press

    Christopher Dye

  31. Reply to Lawn and Wood

    Article • The Journal of Infectious Diseases, April 2007, Oxford University Press (OUP)

    Christopher Dye

  32. HIV Infection, Antiretroviral Therapy, and CD4 + Cell Count Distributions in African Populations

    Article • The Journal of Infectious Diseases, November 2006, Oxford University Press (OUP)

    Christopher Dye

  33. Global Incidence of Multidrug‐Resistant Tuberculosis

    Article • The Journal of Infectious Diseases, August 2006, Oxford University Press (OUP)

    Christopher Dye

  34. Global epidemiology of tuberculosis

    Article • The Lancet, March 2006, Elsevier

    Christopher Dye

  35. The Development and Impact of Tuberculosis Vaccines

    Article • Cell, February 2006, Elsevier

    Christopher Dye

  36. Tuberculosis control in the era of HIV

    Article • Nature Reviews Immunology, October 2005, Springer Science + Business Media

    Christopher Dye

  37. Evolution of Tuberculosis Control and Prospects for Reducing Tuberculosis Incidence, Prevalence, and Deaths Globally

    Article • JAMA, June 2005, American Medical Association (AMA)

    Christopher Dye

  38. Can DOTS control multidrug-resistant tuberculosis?

    Article • The Lancet, April 2005, Elsevier

    Christopher Dye

  39. Human Immunodeficiency Virus and the Prevalence of Undiagnosed Tuberculosis in African Gold Miners

    Article • American Journal of Respiratory and Critical Care Medicine, September 2004, American Thoracic Society

    Christopher Dye

  40. A Booster for Tuberculosis Vaccines

    Article • JAMA, May 2004, American Medical Association (AMA)

    Christopher Dye

  41. Tuberculosis epidemics driven by HIV

    Article • AIDS, November 2003, Wolters Kluwer Health

    Christopher Dye

  42. Tuberculosis

    Article • The Lancet, September 2003, Elsevier

    Christopher Dye

  43. Monitoring mosquito net coverage for malaria control in Africa: possession vs. use by children under 5 years

    Article • Tropical Medicine & International Health, July 2003, Wiley

    Christopher Dye

  44. Effects of Human Immunodeficiency Virus Infection on Recurrence of Tuberculosis after Rifampin‐Based Treatment: An Analytical Review

    Article • Clinical Infectious Diseases, July 2003, Oxford University Press (OUP)

    Christopher Dye

  45. The Growing Burden of Tuberculosis

    Article • Archives of Internal Medicine, May 2003, American Medical Association (AMA)

    Christopher Dye

  46. What is the limit to case detection under the DOTS strategy for tuberculosis control?

    Article • Tuberculosis, February 2003, Elsevier

    Christopher Dye

  47. Infectiousness in a Cohort of Brazilian Dogs: Why Culling Fails to Control Visceral Leishmaniasis in Areas of High Transmission

    Article • The Journal of Infectious Diseases, November 2002, Oxford University Press (OUP)

    Christopher Dye

  48. Worldwide Incidence of Multidrug‐Resistant Tuberculosis

    Article • The Journal of Infectious Diseases, April 2002, Oxford University Press (OUP)

    Christopher Dye

  49. Estimates of world-wide distribution of child deaths from acute respiratory infections

    Article • The Lancet Infectious Diseases, January 2002, Elsevier

    Christopher Dye

  50. The Burden of Drug‐Resistant Tuberculosis and Mechanisms for Its Control

    Article • Annals of the New York Academy of Sciences, December 2001, Wiley

    Christopher Dye

  51. The Dynamics of Tuberculosis in Response to 10 Years of Intensive Control Effort in Peru

    Article • The Journal of Infectious Diseases, August 2001, Oxford University Press (OUP)

    Christopher Dye

  52. Fit but rare? The pros and cons of being a virulent pathogen

    Article • Trends in Ecology & Evolution, August 2001, Elsevier

    Christopher Dye

  53. The TB and HIV/AIDS Epidemics in the Russian Federation

    Article • June 2001

    Christopher Dye

  54. Tissue Cytokine Responses in Canine Visceral Leishmaniasis

    Article • The Journal of Infectious Diseases, May 2001, Oxford University Press (OUP)

    Christopher Dye

  55. Global Trends in Resistance to Antituberculosis Drugs

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, April 2001, New England Journal of Medicine (NEJM/MMS)

    Christopher Dye, Professor JEROME ROBERT

  56. Population dynamics and control of multidrug-resistant tuberculosis

    Article • January 2000, Springer Science + Business Media

    Christopher Dye

  57. Intra and inter-specific microsatellite variation in the Leishmania subgenus Viannia

    Article • Molecular and Biochemical Parasitology, September 1999, Elsevier

    Christopher Dye

  58. Global Burden of TuberculosisSupplemental Appendixes

    Article • JAMA, August 1999, American Medical Association (AMA)

    Christopher Dye

  59. Global Burden of TuberculosisEstimated Incidence, Prevalence, and Mortality by Country

    Article • JAMA, August 1999, American Medical Association (AMA)

    Christopher Dye

  60. Prospects for worldwide tuberculosis control under the WHO DOTS strategy

    Article • The Lancet, December 1998, Elsevier

    Christopher Dye

  61. Assessment of worldwide tuberculosis control

    Article • The Lancet, August 1997, Elsevier

    Christopher Dye

  62. Cutaneous Leishmaniasis in the Peruvian Andes: Factors Associated with Variability in Clinical Symptoms, Response to Treatment, and Parasite Isolation Rate

    Article • Clinical Infectious Diseases, August 1997, Oxford University Press (OUP)

    Christopher Dye

  63. Global burden of disease

    Article • The Lancet, July 1997, Elsevier

    Christopher Dye

  64. Pheromones, kairomones and the aggregation dynamics of the sandflyLutzomyia longipalpis

    Article • Animal Behaviour, April 1997, Elsevier

    Christopher Dye

  65. Differential application of lambda‐cyhalothrin to control the sandfly Lutzomyia longipalpis

    Article • Medical and Veterinary Entomology, January 1997, Wiley

    Christopher Dye

  66. Density-Dependent Feeding Success in a Field Population of the Sandfly, Lutzomyia longipalpis

    Article • Journal of Animal Ecology, July 1996, JSTOR

    Christopher Dye

  67. Serengeti wild dogs: what really happened?

    Article • Trends in Ecology & Evolution, May 1996, Elsevier

    Christopher Dye

  68. Immunization coverage required to prevent outbreaks of dog rabies

    Article • Vaccine, February 1996, Elsevier

    Christopher Dye

  69. Extensive polymorphism at the Gp63 locus in field isolates of Leishmania peruviana

    Article • Molecular and Biochemical Parasitology, June 1995, Elsevier

    Christopher Dye

  70. An experimental study of the peridomestic distribution of Lutzomyia longipalpis (Diptera: Psychodidae)

    Article • Bulletin of Entomological Research, September 1994, Cambridge University Press

    Christopher Dye

  71. A theory of malaria vaccination

    Article • Nature, July 1994, Springer Science + Business Media

    Christopher Dye

  72. Immunoassays for tropical parasitic infections: how sensitive and specific?

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, May 1994, Oxford University Press (OUP)

    Christopher Dye

  73. 5. The epidemiological context of vector control

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, March 1994, Oxford University Press (OUP)

    Christopher Dye

  74. Bloodsucking Arthropods

    Article • August 1992, Wiley

    Christopher Dye

  75. The Analysis of Parasite Transmission by Bloodsucking Insects

    Article • Annual Review of Entomology, January 1992, Annual Reviews

    Christopher Dye

  76. Infectious diseases of humans: Dynamics and control

    Article • Trends in Ecology & Evolution, October 1991, Elsevier

    Christopher Dye

  77. Communication among phlebotomine sandflies: a field study of domesticated Lutzomyia longipalpis populations in Amazonian Brazil

    Article • Animal Behaviour, August 1991, Elsevier

    Christopher Dye

  78. Bird-parasite interactions: Ecology, evolution and behaviour

    Article • Parasitology Today, January 1991, Elsevier

    Christopher Dye

  79. Stage-Structured Populations: Sampling, Analysis and Simulation.

    Article • Journal of the Royal Statistical Society Series A (Statistics in Society), January 1991, JSTOR

    Christopher Dye

  80. Highly efficient dry season transmission of malaria in Thailand: in defence of Rosenberg et al.

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, January 1991, Oxford University Press (OUP)

    Christopher Dye

  81. Glasnost and the great gerbil: Virulence polymorphisms in the epidemiology of leishmaniasis

    Article • Trends in Ecology & Evolution, August 1990, Elsevier

    Christopher Dye

  82. Why Measure the Vectorial Capacity of Sandflies?

    Article • January 1989, Springer Science + Business Media

    Christopher Dye

  83. Earthquakes, influenza and cycles of Indian kala-azar

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, November 1988, Oxford University Press (OUP)

    Christopher Dye

  84. Population ecology of individuals (monographs in population biology 25)

    Article • Trends in Ecology & Evolution, August 1988, Elsevier

    Christopher Dye

  85. The epidemiology of canine visceral leishmaniasis in southern France: classical theory offers another explanation of the data

    Article • Parasitology, February 1988, Cambridge University Press

    Christopher Dye

  86. Population dynamics of mosquito-borne disease: Persistence in a completely heterogeneous environment

    Article • Theoretical Population Biology, February 1988, Elsevier

    Christopher Dye

  87. Population dynamics of mosquito-borne disease: effects of flies which bite some people more frequently than others

    Article • Transactions of the Royal Society of Tropical Medicine and Hygiene, January 1986, Oxford University Press (OUP)

    Christopher Dye

  88. Competition amongst larval Aedes aegypti: the role of interference

    Article • Ecological Entomology, August 1984, Wiley

    Christopher Dye

  89. Models for the Population Dynamics of the Yellow Fever Mosquito, Aedes aegypti

    Article • Journal of Animal Ecology, February 1984, JSTOR

    Christopher Dye

  90. Intraspecific competition amongst larval Aedes aegypti: food exploitation or chemical interference?

    Article • Ecological Entomology, February 1982, Wiley

    Christopher Dye